Hypofractionated stereotactic radiosurgery with concurrent bevacizumab for recurrent malignant gliomas: the University of Alabama at Birmingham experience

BACKGROUND: Nearly all patients with malignant glioma will have disease recurrence. Our purpose was to define the treatment toxicity and efficacy of concurrent bevazicumab (BVZ) with hypofractionated stereotactic radiosurgery (SRS) of relatively larger targets for patients with recurrent MG. METHODS...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurooncol Pract
Main Authors: Clark, Grant M., McDonald, Andrew M., Nabors, Louis B., Fathalla-Shaykh, Hassan, Han, Xiaosi, Willey, Christopher D., Markert, James M., Guthrie, Barton L., Bredel, Markus, Fiveash, John B.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2014
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4369713/
https://ncbi.nlm.nih.gov/pubmed/26034629
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nop/npu028
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados